ArticleInfection & chemotherapy2022

Use of the Monoclonal Antibody Regdanvimab to Treat Patients Hospitalized with COVID-19: Real-World Data during the Delta Variant Predominance.

Yee Gyung Kwak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.